Approves Robinson, Gebhard Bill to Improve Treatments for Cancer, ALS, Parkinson’s Disease in Pennsylvania

HARRISBURG - Legislation to improve treatment access and outcomes for cancer, amyotrophic lateral sclerosis (ALS), and other serious conditions in Pennsylvania was unanimously passed by the state Senate, according to the bill's sponsors Sens. Devlin Robinson (R-37) and Chris Gebhard (R-48).

Last session, Robinson partnered with Rep. Kyle Mullins (D-112) to sponsor legislation that was ultimately signed into law as Act 39 of 2024 to provide Pennsylvanians with better access to personalized treatments following a diagnosis of cancer and other specific diseases through biomarker testing and precision medicine.

"Unfortunately, it has come to our attention that the Department of Human Services has been denying coverage for certain biomarker tests under the Medicaid fee-for-service program," the senators said. "Our bill would clarify that the department must extend coverage to Pennsylvanians with insurance through Medicaid fee-for-service, ensuring more underserved Pennsylvanians have access to clinically proven biomarker testing for diseases like cancer, ALS, Parkinson's disease, and more."

Senate Bill 1211 would make it clear that Pennsylvanians who utilize a health insurance plan under the jurisdiction of the Commonwealth will have coverage for biomarker tests, which have proven to increase health, recovery, and even financial benefits for Pennsylvanians.

Biomarker testing looks for biological changes at a molecular level, giving doctors and patients more specific information about their diagnosis to ensure they get the right treatment options for their individual needs. It can also help inform doctors creating treatment plans by providing predictions of the growth and spread of disease.

"By expanding access to biomarker testing and precision medicine, we can detect diseases and tailor treatments to the individual needs of each patient," the senators said. "Our bill would codify the true intent of Act 39 of 2024 into law while strengthening the original measure to address critical disparities in care, ensuring that Pennsylvanians from all socioeconomic backgrounds have access to these life-saving advancements."

The bill will now be referred to the House of Representatives for consideration.

VIDEO: Sen. Robinson remarks in favor of SB1211 on the Senate floor

CONTACT: